EUVIMEDScopri EUVIMED
Crossref

Percutaneous Endovascular Management of MANTA‐Related Vascular Occlusion

Dan Haberman iD, Rama Alkhofash, Evan Czulada iD, Lior Lupu, Waiel Abusnina iD, Kalyan R Chitturi iD, Abhishek Chaturvedi, Jason Galo iD, Beni Verma, Toby Rogers, Lowell F Satler iD, Nelson L Bernardo and 2 more

Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1945-1952

DOI: 10.1002/ccd.70556 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2026-03-16. Written by Dan Haberman and 13 co-authors. Institution: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, USA. Major MEDLINE topics: Femoral Artery, Endovascular Procedures, Hemostatic Techniques, Arterial Occlusive Diseases. Cited 1 times so far (Crossref); 22 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Vascular closure devices (VCDs) are the standard alternative to surgical cutdown for large‐bore arterial access (LBAA) but can lead to complications like bleeding and common femoral artery (CFA) occlusion that require intervention. This manuscript outlines our approach using percutaneous endovascular intervention (PEI) to manage femoral artery occlusion caused by the MANTA (Teleflex, Morrisville, SC), the only collagen plug‐based VCD indicated for LBAA.

Methods

Consecutive patients who experienced occlusive complications following MANTA deployment at the conclusion of transcutaneous aortic valve replacement (TAVR) underwent PEI to address occlusion. Clinical and procedural characteristics of the patients, as well as their short‐ and long‐term follow‐up data, were analyzed.

Results

A total of 1445 patients underwent TAVR, in whom LBAA was closed with MANTA VCD between August 2017 and July 2024, among whom 34 patients (2.4%) experienced occlusive complications. These patients had a mean age of 79 ± 8 years, and 59% were female. The mean CFA diameter was 7.8 ± 1.1 mm, with mild vessel stenosis present in 41% and calcification in 44% of patients. An 18 French MANTA device was used for closure in 82% of patients. The primary mechanism was plug internalization, which was observed in 88% of our cohort and led to total vessel occlusion in 56% of patients. Bleeding occurred in 38% of patients in association with occlusion. All patients were approached with PEI, achieving an overall procedural success rate of 97%. Lesion crossing was accomplished via an antegrade approach in 71% of patients, with the remaining 29% requiring a retrograde approach. Stenting was the definitive treatment in 85% of patients, with 90% of these involving an oversized VIABAHN (Gore Medical, Newark, DE) self‐expanding stent. One patient experienced profunda artery occlusion after stent placement that required surgery. At 1‐month follow‐up, no vessel occlusions or bleeding were reported.

Conclusion

Femoral artery occlusion from MANTA deployment after TAVR can be effectively treated with PEI. Low complication rates at 1 month suggest PEI is safe and reliable, but longer follow‐up is needed to assess long‐term vessel outcomes.

Subjects

MeSH terms (MEDLINE)

Femoral ArteryEndovascular ProceduresHemostatic TechniquesArterial Occlusive DiseasesCatheterization, PeripheralVascular Closure DevicesHumansFemaleTreatment OutcomeTime FactorsAgedMaleAged, 80 and overPuncturesRisk FactorsRetrospective StudiesHemorrhage

Author keywords

MANTAcovered stentfemoral artery occlusionpercutaneous endovascular interventionvascular closure device

Authors and institutions

  • Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, USA.
  • Georgetown University School of Medicine, Washington, USA.
  • Cardiovascular Intervention Program, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.

ORCID profiles: Dan Haberman, Evan Czulada, Waiel Abusnina, Kalyan R Chitturi, Jason Galo, Lowell F Satler, Ron Waksman, Itsik Ben-Dor

Cite

APA

Haberman, D., Alkhofash, R., Czulada, E., Lupu, L., Abusnina, W., Chitturi, K. R., Chaturvedi, A., Galo, J., Verma, B., Rogers, T., Satler, L. F., Bernardo, N. L., Waksman, R., & Ben-Dor, I. (2026). Percutaneous Endovascular Management of MANTA‐Related Vascular Occlusion. Catheterization and Cardiovascular Interventions, 107(6), 1945-1952. https://doi.org/10.1002/ccd.70556

Vancouver

Haberman D, Alkhofash R, Czulada E, Lupu L, Abusnina W, Chitturi KR, et al. Percutaneous Endovascular Management of MANTA‐Related Vascular Occlusion. Catheterization and Cardiovascular Interventions. 2026;107(6):1945-1952. doi:10.1002/ccd.70556

BibTeX
@article{Haberman2026,
  author = {Haberman, Dan and Alkhofash, Rama and Czulada, Evan and Lupu, Lior and Abusnina, Waiel and Chitturi, Kalyan R and Chaturvedi, Abhishek and Galo, Jason and Verma, Beni and Rogers, Toby and Satler, Lowell F and Bernardo, Nelson L and Waksman, Ron and Ben-Dor, Itsik},
  title = {Percutaneous Endovascular Management of MANTA‐Related Vascular Occlusion},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {6},
  pages = {1945--1952},
  doi = {10.1002/ccd.70556}
}
Start for free →